Global Alzheimer's Blood Tests Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Alzheimer's Blood Tests market size was valued at US$ 74.24 million in 2025 and is forecast to a readjusted size of US$ 131 million by 2032 with a CAGR of 8.4% during review period.
Alzheimer's blood tests refer to diagnostic or biomarker testing methods that analyze Alzheimer's disease-related biomarkers in peripheral blood samples. These tests are designed to support the assessment of amyloid pathology, tau abnormalities, neurodegeneration, and neuroinflammation associated with Alzheimer's disease. Compared with cerebrospinal fluid testing and PET imaging, blood-based tests are less invasive, easier to perform, more accessible, and relatively more cost-effective. They are mainly used for diagnostic support in patients with cognitive impairment, clinical triage, treatment eligibility assessment, disease monitoring, and subject screening in drug development and clinical trials. The average price for end-point testing services is approximately US$500?900 per test.
The upstream supply chain of Alzheimer's blood tests mainly includes antibodies, recombinant proteins, calibrators, quality controls, magnetic beads, enzyme labels, chemiluminescent substrates, assay raw materials, sample preparation consumables, chemiluminescent platforms, single-molecule immunoassay platforms, mass spectrometry systems, and related algorithms and data analysis software. The midstream segment consists of blood-based diagnostic product and platform companies that develop assays, instruments, and multi-biomarker panels targeting markers such as pTau, A?, NfL, GFAP, and ApoE. The downstream segment includes neurology departments, memory clinics, independent clinical laboratories, specialty testing centers, pharmaceutical companies, CROs, universities, and research institutions, with applications covering clinical diagnostic support, patient stratification, treatment monitoring, clinical trial enrollment, and Alzheimer's disease biomarker research.
The Alzheimer's blood tests market is entering a critical transition phase from research validation to clinical commercialization. With growing clinical evidence for blood-based biomarkers such as pTau, A?, NfL, and GFAP, and increasing demand for patient screening and stratification driven by anti-amyloid therapies, blood tests are expected to become an important supporting tool in the Alzheimer?s disease diagnostic pathway. Compared with PET imaging and cerebrospinal fluid testing, blood-based tests offer clear advantages in convenience, accessibility, and cost efficiency, making them particularly suitable for clinical triage, treatment eligibility assessment, and broader patient pre-screening. Future market growth will be driven by improvements in test accuracy, regulatory progress, physician adoption, laboratory channel expansion, and rising demand from drug development. However, the market still faces challenges related to clinical guideline adoption, reimbursement, assay standardization, and comparability across different technology platforms.
This report is a detailed and comprehensive analysis for global Alzheimer's Blood Tests market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Alzheimer's Blood Tests market size and forecasts, in consumption value ($ Million), 2021-2032
Global Alzheimer's Blood Tests market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Alzheimer's Blood Tests market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Alzheimer's Blood Tests market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Alzheimer's Blood Tests market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Alzheimer's blood tests refer to diagnostic or biomarker testing methods that analyze Alzheimer's disease-related biomarkers in peripheral blood samples. These tests are designed to support the assessment of amyloid pathology, tau abnormalities, neurodegeneration, and neuroinflammation associated with Alzheimer's disease. Compared with cerebrospinal fluid testing and PET imaging, blood-based tests are less invasive, easier to perform, more accessible, and relatively more cost-effective. They are mainly used for diagnostic support in patients with cognitive impairment, clinical triage, treatment eligibility assessment, disease monitoring, and subject screening in drug development and clinical trials. The average price for end-point testing services is approximately US$500?900 per test.
The upstream supply chain of Alzheimer's blood tests mainly includes antibodies, recombinant proteins, calibrators, quality controls, magnetic beads, enzyme labels, chemiluminescent substrates, assay raw materials, sample preparation consumables, chemiluminescent platforms, single-molecule immunoassay platforms, mass spectrometry systems, and related algorithms and data analysis software. The midstream segment consists of blood-based diagnostic product and platform companies that develop assays, instruments, and multi-biomarker panels targeting markers such as pTau, A?, NfL, GFAP, and ApoE. The downstream segment includes neurology departments, memory clinics, independent clinical laboratories, specialty testing centers, pharmaceutical companies, CROs, universities, and research institutions, with applications covering clinical diagnostic support, patient stratification, treatment monitoring, clinical trial enrollment, and Alzheimer's disease biomarker research.
The Alzheimer's blood tests market is entering a critical transition phase from research validation to clinical commercialization. With growing clinical evidence for blood-based biomarkers such as pTau, A?, NfL, and GFAP, and increasing demand for patient screening and stratification driven by anti-amyloid therapies, blood tests are expected to become an important supporting tool in the Alzheimer?s disease diagnostic pathway. Compared with PET imaging and cerebrospinal fluid testing, blood-based tests offer clear advantages in convenience, accessibility, and cost efficiency, making them particularly suitable for clinical triage, treatment eligibility assessment, and broader patient pre-screening. Future market growth will be driven by improvements in test accuracy, regulatory progress, physician adoption, laboratory channel expansion, and rising demand from drug development. However, the market still faces challenges related to clinical guideline adoption, reimbursement, assay standardization, and comparability across different technology platforms.
This report is a detailed and comprehensive analysis for global Alzheimer's Blood Tests market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Alzheimer's Blood Tests market size and forecasts, in consumption value ($ Million), 2021-2032
Global Alzheimer's Blood Tests market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Alzheimer's Blood Tests market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Alzheimer's Blood Tests market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Alzheimer's Blood Tests
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Alzheimer's Blood Tests market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Single Biomarker Tests
- Multi-Biomarker Panel Tests
- Others
- Chemiluminescent Immunoassay
- Single-Molecule and Ultra-Sensitive Immunoassay
- Mass Spectrometry-Based Testing
- Others
- Commercialized Products
- Products under Development or Registration
- Research Use Only Products
- Clinical Use
- Non-Clinical Use
- Roche
- Fujirebio
- Sysmex
- Shimadzu
- Diadem
- Quanterix
- ALZpath
- Beckman Coulter Diagnostics
- Siemens Healthineers
- Vazyme
- Hoyotek
- BGI Genomics
- Kemei Diagnostics
- Maya Lightyear
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
- Chapter 1, to describe Alzheimer's Blood Tests product scope, market overview, market estimation caveats and base year.
- Chapter 2, to profile the top players of Alzheimer's Blood Tests, with revenue, gross margin, and global market share of Alzheimer's Blood Tests from 2021 to 2026.
- Chapter 3, the Alzheimer's Blood Tests competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
- Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
- Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Alzheimer's Blood Tests market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
- Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
- Chapter 12, the key raw materials and key suppliers, and industry chain of Alzheimer's Blood Tests.
- Chapter 13, to describe Alzheimer's Blood Tests research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Alzheimer's Blood Tests by Type
1.3.1 Overview: Global Alzheimer's Blood Tests Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Alzheimer's Blood Tests Consumption Value Market Share by Type in 2025
1.3.3 Single Biomarker Tests
1.3.4 Multi-Biomarker Panel Tests
1.3.5 Others
1.4 Classification of Alzheimer's Blood Tests Testing Technology
1.4.1 Overview: Global Alzheimer's Blood Tests Market Size Testing Technology: 2021 Versus 2025 Versus 2032
1.4.2 Global Alzheimer's Blood Tests Consumption Value Market Share Testing Technology in 2025
1.4.3 Chemiluminescent Immunoassay
1.4.4 Single-Molecule and Ultra-Sensitive Immunoassay
1.4.5 Mass Spectrometry-Based Testing
1.4.6 Others
1.5 Classification of Alzheimer's Blood Tests Commercialization Status
1.5.1 Overview: Global Alzheimer's Blood Tests Market Size Commercialization Status: 2021 Versus 2025 Versus 2032
1.5.2 Global Alzheimer's Blood Tests Consumption Value Market Share Commercialization Status in 2025
1.5.3 Commercialized Products
1.5.4 Products under Development or Registration
1.5.5 Research Use Only Products
1.6 Global Alzheimer's Blood Tests Market by Application
1.6.1 Overview: Global Alzheimer's Blood Tests Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Clinical Use
1.6.3 Non-Clinical Use
1.7 Global Alzheimer's Blood Tests Market Size & Forecast
1.8 Global Alzheimer's Blood Tests Market Size and Forecast by Region
1.8.1 Global Alzheimer's Blood Tests Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Alzheimer's Blood Tests Market Size by Region, (2021-2032)
1.8.3 North America Alzheimer's Blood Tests Market Size and Prospect (2021-2032)
1.8.4 Europe Alzheimer's Blood Tests Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Alzheimer's Blood Tests Market Size and Prospect (2021-2032)
1.8.6 South America Alzheimer's Blood Tests Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Alzheimer's Blood Tests Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Alzheimer's Blood Tests Product and Solutions
2.1.4 Roche Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Roche Recent Developments and Future Plans
2.2 Fujirebio
2.2.1 Fujirebio Details
2.2.2 Fujirebio Major Business
2.2.3 Fujirebio Alzheimer's Blood Tests Product and Solutions
2.2.4 Fujirebio Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Fujirebio Recent Developments and Future Plans
2.3 Sysmex
2.3.1 Sysmex Details
2.3.2 Sysmex Major Business
2.3.3 Sysmex Alzheimer's Blood Tests Product and Solutions
2.3.4 Sysmex Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Sysmex Recent Developments and Future Plans
2.4 Shimadzu
2.4.1 Shimadzu Details
2.4.2 Shimadzu Major Business
2.4.3 Shimadzu Alzheimer's Blood Tests Product and Solutions
2.4.4 Shimadzu Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Shimadzu Recent Developments and Future Plans
2.5 Diadem
2.5.1 Diadem Details
2.5.2 Diadem Major Business
2.5.3 Diadem Alzheimer's Blood Tests Product and Solutions
2.5.4 Diadem Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Diadem Recent Developments and Future Plans
2.6 Quanterix
2.6.1 Quanterix Details
2.6.2 Quanterix Major Business
2.6.3 Quanterix Alzheimer's Blood Tests Product and Solutions
2.6.4 Quanterix Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Quanterix Recent Developments and Future Plans
2.7 ALZpath
2.7.1 ALZpath Details
2.7.2 ALZpath Major Business
2.7.3 ALZpath Alzheimer's Blood Tests Product and Solutions
2.7.4 ALZpath Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 ALZpath Recent Developments and Future Plans
2.8 Beckman Coulter Diagnostics
2.8.1 Beckman Coulter Diagnostics Details
2.8.2 Beckman Coulter Diagnostics Major Business
2.8.3 Beckman Coulter Diagnostics Alzheimer's Blood Tests Product and Solutions
2.8.4 Beckman Coulter Diagnostics Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Beckman Coulter Diagnostics Recent Developments and Future Plans
2.9 Siemens Healthineers
2.9.1 Siemens Healthineers Details
2.9.2 Siemens Healthineers Major Business
2.9.3 Siemens Healthineers Alzheimer's Blood Tests Product and Solutions
2.9.4 Siemens Healthineers Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Siemens Healthineers Recent Developments and Future Plans
2.10 Vazyme
2.10.1 Vazyme Details
2.10.2 Vazyme Major Business
2.10.3 Vazyme Alzheimer's Blood Tests Product and Solutions
2.10.4 Vazyme Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Vazyme Recent Developments and Future Plans
2.11 Hoyotek
2.11.1 Hoyotek Details
2.11.2 Hoyotek Major Business
2.11.3 Hoyotek Alzheimer's Blood Tests Product and Solutions
2.11.4 Hoyotek Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Hoyotek Recent Developments and Future Plans
2.12 BGI Genomics
2.12.1 BGI Genomics Details
2.12.2 BGI Genomics Major Business
2.12.3 BGI Genomics Alzheimer's Blood Tests Product and Solutions
2.12.4 BGI Genomics Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 BGI Genomics Recent Developments and Future Plans
2.13 Kemei Diagnostics
2.13.1 Kemei Diagnostics Details
2.13.2 Kemei Diagnostics Major Business
2.13.3 Kemei Diagnostics Alzheimer's Blood Tests Product and Solutions
2.13.4 Kemei Diagnostics Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Kemei Diagnostics Recent Developments and Future Plans
2.14 Maya Lightyear
2.14.1 Maya Lightyear Details
2.14.2 Maya Lightyear Major Business
2.14.3 Maya Lightyear Alzheimer's Blood Tests Product and Solutions
2.14.4 Maya Lightyear Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Maya Lightyear Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Alzheimer's Blood Tests Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Alzheimer's Blood Tests by Company Revenue
3.2.2 Top 3 Alzheimer's Blood Tests Players Market Share in 2025
3.2.3 Top 6 Alzheimer's Blood Tests Players Market Share in 2025
3.3 Alzheimer's Blood Tests Market: Overall Company Footprint Analysis
3.3.1 Alzheimer's Blood Tests Market: Region Footprint
3.3.2 Alzheimer's Blood Tests Market: Company Product Type Footprint
3.3.3 Alzheimer's Blood Tests Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Alzheimer's Blood Tests Consumption Value and Market Share by Type (2021-2026)
4.2 Global Alzheimer's Blood Tests Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Alzheimer's Blood Tests Consumption Value Market Share by Application (2021-2026)
5.2 Global Alzheimer's Blood Tests Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Alzheimer's Blood Tests Consumption Value by Type (2021-2032)
6.2 North America Alzheimer's Blood Tests Market Size by Application (2021-2032)
6.3 North America Alzheimer's Blood Tests Market Size by Country
6.3.1 North America Alzheimer's Blood Tests Consumption Value by Country (2021-2032)
6.3.2 United States Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
6.3.3 Canada Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
6.3.4 Mexico Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Alzheimer's Blood Tests Consumption Value by Type (2021-2032)
7.2 Europe Alzheimer's Blood Tests Consumption Value by Application (2021-2032)
7.3 Europe Alzheimer's Blood Tests Market Size by Country
7.3.1 Europe Alzheimer's Blood Tests Consumption Value by Country (2021-2032)
7.3.2 Germany Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
7.3.3 France Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
7.3.5 Russia Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
7.3.6 Italy Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Alzheimer's Blood Tests Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Alzheimer's Blood Tests Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Alzheimer's Blood Tests Market Size by Region
8.3.1 Asia-Pacific Alzheimer's Blood Tests Consumption Value by Region (2021-2032)
8.3.2 China Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
8.3.3 Japan Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
8.3.4 South Korea Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
8.3.5 India Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
8.3.7 Australia Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Alzheimer's Blood Tests Consumption Value by Type (2021-2032)
9.2 South America Alzheimer's Blood Tests Consumption Value by Application (2021-2032)
9.3 South America Alzheimer's Blood Tests Market Size by Country
9.3.1 South America Alzheimer's Blood Tests Consumption Value by Country (2021-2032)
9.3.2 Brazil Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
9.3.3 Argentina Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Alzheimer's Blood Tests Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Alzheimer's Blood Tests Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Alzheimer's Blood Tests Market Size by Country
10.3.1 Middle East & Africa Alzheimer's Blood Tests Consumption Value by Country (2021-2032)
10.3.2 Turkey Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
10.3.4 UAE Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Alzheimer's Blood Tests Market Drivers
11.2 Alzheimer's Blood Tests Market Restraints
11.3 Alzheimer's Blood Tests Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Alzheimer's Blood Tests Industry Chain
12.2 Alzheimer's Blood Tests Upstream Analysis
12.3 Alzheimer's Blood Tests Midstream Analysis
12.4 Alzheimer's Blood Tests Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Alzheimer's Blood Tests by Type
1.3.1 Overview: Global Alzheimer's Blood Tests Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Alzheimer's Blood Tests Consumption Value Market Share by Type in 2025
1.3.3 Single Biomarker Tests
1.3.4 Multi-Biomarker Panel Tests
1.3.5 Others
1.4 Classification of Alzheimer's Blood Tests Testing Technology
1.4.1 Overview: Global Alzheimer's Blood Tests Market Size Testing Technology: 2021 Versus 2025 Versus 2032
1.4.2 Global Alzheimer's Blood Tests Consumption Value Market Share Testing Technology in 2025
1.4.3 Chemiluminescent Immunoassay
1.4.4 Single-Molecule and Ultra-Sensitive Immunoassay
1.4.5 Mass Spectrometry-Based Testing
1.4.6 Others
1.5 Classification of Alzheimer's Blood Tests Commercialization Status
1.5.1 Overview: Global Alzheimer's Blood Tests Market Size Commercialization Status: 2021 Versus 2025 Versus 2032
1.5.2 Global Alzheimer's Blood Tests Consumption Value Market Share Commercialization Status in 2025
1.5.3 Commercialized Products
1.5.4 Products under Development or Registration
1.5.5 Research Use Only Products
1.6 Global Alzheimer's Blood Tests Market by Application
1.6.1 Overview: Global Alzheimer's Blood Tests Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Clinical Use
1.6.3 Non-Clinical Use
1.7 Global Alzheimer's Blood Tests Market Size & Forecast
1.8 Global Alzheimer's Blood Tests Market Size and Forecast by Region
1.8.1 Global Alzheimer's Blood Tests Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Alzheimer's Blood Tests Market Size by Region, (2021-2032)
1.8.3 North America Alzheimer's Blood Tests Market Size and Prospect (2021-2032)
1.8.4 Europe Alzheimer's Blood Tests Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Alzheimer's Blood Tests Market Size and Prospect (2021-2032)
1.8.6 South America Alzheimer's Blood Tests Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Alzheimer's Blood Tests Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Alzheimer's Blood Tests Product and Solutions
2.1.4 Roche Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Roche Recent Developments and Future Plans
2.2 Fujirebio
2.2.1 Fujirebio Details
2.2.2 Fujirebio Major Business
2.2.3 Fujirebio Alzheimer's Blood Tests Product and Solutions
2.2.4 Fujirebio Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Fujirebio Recent Developments and Future Plans
2.3 Sysmex
2.3.1 Sysmex Details
2.3.2 Sysmex Major Business
2.3.3 Sysmex Alzheimer's Blood Tests Product and Solutions
2.3.4 Sysmex Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Sysmex Recent Developments and Future Plans
2.4 Shimadzu
2.4.1 Shimadzu Details
2.4.2 Shimadzu Major Business
2.4.3 Shimadzu Alzheimer's Blood Tests Product and Solutions
2.4.4 Shimadzu Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Shimadzu Recent Developments and Future Plans
2.5 Diadem
2.5.1 Diadem Details
2.5.2 Diadem Major Business
2.5.3 Diadem Alzheimer's Blood Tests Product and Solutions
2.5.4 Diadem Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Diadem Recent Developments and Future Plans
2.6 Quanterix
2.6.1 Quanterix Details
2.6.2 Quanterix Major Business
2.6.3 Quanterix Alzheimer's Blood Tests Product and Solutions
2.6.4 Quanterix Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Quanterix Recent Developments and Future Plans
2.7 ALZpath
2.7.1 ALZpath Details
2.7.2 ALZpath Major Business
2.7.3 ALZpath Alzheimer's Blood Tests Product and Solutions
2.7.4 ALZpath Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 ALZpath Recent Developments and Future Plans
2.8 Beckman Coulter Diagnostics
2.8.1 Beckman Coulter Diagnostics Details
2.8.2 Beckman Coulter Diagnostics Major Business
2.8.3 Beckman Coulter Diagnostics Alzheimer's Blood Tests Product and Solutions
2.8.4 Beckman Coulter Diagnostics Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Beckman Coulter Diagnostics Recent Developments and Future Plans
2.9 Siemens Healthineers
2.9.1 Siemens Healthineers Details
2.9.2 Siemens Healthineers Major Business
2.9.3 Siemens Healthineers Alzheimer's Blood Tests Product and Solutions
2.9.4 Siemens Healthineers Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Siemens Healthineers Recent Developments and Future Plans
2.10 Vazyme
2.10.1 Vazyme Details
2.10.2 Vazyme Major Business
2.10.3 Vazyme Alzheimer's Blood Tests Product and Solutions
2.10.4 Vazyme Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Vazyme Recent Developments and Future Plans
2.11 Hoyotek
2.11.1 Hoyotek Details
2.11.2 Hoyotek Major Business
2.11.3 Hoyotek Alzheimer's Blood Tests Product and Solutions
2.11.4 Hoyotek Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Hoyotek Recent Developments and Future Plans
2.12 BGI Genomics
2.12.1 BGI Genomics Details
2.12.2 BGI Genomics Major Business
2.12.3 BGI Genomics Alzheimer's Blood Tests Product and Solutions
2.12.4 BGI Genomics Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 BGI Genomics Recent Developments and Future Plans
2.13 Kemei Diagnostics
2.13.1 Kemei Diagnostics Details
2.13.2 Kemei Diagnostics Major Business
2.13.3 Kemei Diagnostics Alzheimer's Blood Tests Product and Solutions
2.13.4 Kemei Diagnostics Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Kemei Diagnostics Recent Developments and Future Plans
2.14 Maya Lightyear
2.14.1 Maya Lightyear Details
2.14.2 Maya Lightyear Major Business
2.14.3 Maya Lightyear Alzheimer's Blood Tests Product and Solutions
2.14.4 Maya Lightyear Alzheimer's Blood Tests Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Maya Lightyear Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Alzheimer's Blood Tests Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Alzheimer's Blood Tests by Company Revenue
3.2.2 Top 3 Alzheimer's Blood Tests Players Market Share in 2025
3.2.3 Top 6 Alzheimer's Blood Tests Players Market Share in 2025
3.3 Alzheimer's Blood Tests Market: Overall Company Footprint Analysis
3.3.1 Alzheimer's Blood Tests Market: Region Footprint
3.3.2 Alzheimer's Blood Tests Market: Company Product Type Footprint
3.3.3 Alzheimer's Blood Tests Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Alzheimer's Blood Tests Consumption Value and Market Share by Type (2021-2026)
4.2 Global Alzheimer's Blood Tests Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Alzheimer's Blood Tests Consumption Value Market Share by Application (2021-2026)
5.2 Global Alzheimer's Blood Tests Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Alzheimer's Blood Tests Consumption Value by Type (2021-2032)
6.2 North America Alzheimer's Blood Tests Market Size by Application (2021-2032)
6.3 North America Alzheimer's Blood Tests Market Size by Country
6.3.1 North America Alzheimer's Blood Tests Consumption Value by Country (2021-2032)
6.3.2 United States Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
6.3.3 Canada Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
6.3.4 Mexico Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Alzheimer's Blood Tests Consumption Value by Type (2021-2032)
7.2 Europe Alzheimer's Blood Tests Consumption Value by Application (2021-2032)
7.3 Europe Alzheimer's Blood Tests Market Size by Country
7.3.1 Europe Alzheimer's Blood Tests Consumption Value by Country (2021-2032)
7.3.2 Germany Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
7.3.3 France Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
7.3.5 Russia Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
7.3.6 Italy Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Alzheimer's Blood Tests Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Alzheimer's Blood Tests Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Alzheimer's Blood Tests Market Size by Region
8.3.1 Asia-Pacific Alzheimer's Blood Tests Consumption Value by Region (2021-2032)
8.3.2 China Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
8.3.3 Japan Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
8.3.4 South Korea Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
8.3.5 India Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
8.3.7 Australia Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Alzheimer's Blood Tests Consumption Value by Type (2021-2032)
9.2 South America Alzheimer's Blood Tests Consumption Value by Application (2021-2032)
9.3 South America Alzheimer's Blood Tests Market Size by Country
9.3.1 South America Alzheimer's Blood Tests Consumption Value by Country (2021-2032)
9.3.2 Brazil Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
9.3.3 Argentina Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Alzheimer's Blood Tests Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Alzheimer's Blood Tests Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Alzheimer's Blood Tests Market Size by Country
10.3.1 Middle East & Africa Alzheimer's Blood Tests Consumption Value by Country (2021-2032)
10.3.2 Turkey Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
10.3.4 UAE Alzheimer's Blood Tests Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Alzheimer's Blood Tests Market Drivers
11.2 Alzheimer's Blood Tests Market Restraints
11.3 Alzheimer's Blood Tests Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Alzheimer's Blood Tests Industry Chain
12.2 Alzheimer's Blood Tests Upstream Analysis
12.3 Alzheimer's Blood Tests Midstream Analysis
12.4 Alzheimer's Blood Tests Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Alzheimer's Blood Tests Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Alzheimer's Blood Tests Consumption Value Testing Technology, (USD Million), 2021 & 2025 & 2032
Table 3. Global Alzheimer's Blood Tests Consumption Value Commercialization Status, (USD Million), 2021 & 2025 & 2032
Table 4. Global Alzheimer's Blood Tests Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Alzheimer's Blood Tests Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Alzheimer's Blood Tests Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Roche Company Information, Head Office, and Major Competitors
Table 8. Roche Major Business
Table 9. Roche Alzheimer's Blood Tests Product and Solutions
Table 10. Roche Alzheimer's Blood Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Roche Recent Developments and Future Plans
Table 12. Fujirebio Company Information, Head Office, and Major Competitors
Table 13. Fujirebio Major Business
Table 14. Fujirebio Alzheimer's Blood Tests Product and Solutions
Table 15. Fujirebio Alzheimer's Blood Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Fujirebio Recent Developments and Future Plans
Table 17. Sysmex Company Information, Head Office, and Major Competitors
Table 18. Sysmex Major Business
Table 19. Sysmex Alzheimer's Blood Tests Product and Solutions
Table 20. Sysmex Alzheimer's Blood Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. Shimadzu Company Information, Head Office, and Major Competitors
Table 22. Shimadzu Major Business
Table 23. Shimadzu Alzheimer's Blood Tests Product and Solutions
Table 24. Shimadzu Alzheimer's Blood Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. Shimadzu Recent Developments and Future Plans
Table 26. Diadem Company Information, Head Office, and Major Competitors
Table 27. Diadem Major Business
Table 28. Diadem Alzheimer's Blood Tests Product and Solutions
Table 29. Diadem Alzheimer's Blood Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Diadem Recent Developments and Future Plans
Table 31. Quanterix Company Information, Head Office, and Major Competitors
Table 32. Quanterix Major Business
Table 33. Quanterix Alzheimer's Blood Tests Product and Solutions
Table 34. Quanterix Alzheimer's Blood Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Quanterix Recent Developments and Future Plans
Table 36. ALZpath Company Information, Head Office, and Major Competitors
Table 37. ALZpath Major Business
Table 38. ALZpath Alzheimer's Blood Tests Product and Solutions
Table 39. ALZpath Alzheimer's Blood Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. ALZpath Recent Developments and Future Plans
Table 41. Beckman Coulter Diagnostics Company Information, Head Office, and Major Competitors
Table 42. Beckman Coulter Diagnostics Major Business
Table 43. Beckman Coulter Diagnostics Alzheimer's Blood Tests Product and Solutions
Table 44. Beckman Coulter Diagnostics Alzheimer's Blood Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Beckman Coulter Diagnostics Recent Developments and Future Plans
Table 46. Siemens Healthineers Company Information, Head Office, and Major Competitors
Table 47. Siemens Healthineers Major Business
Table 48. Siemens Healthineers Alzheimer's Blood Tests Product and Solutions
Table 49. Siemens Healthineers Alzheimer's Blood Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Siemens Healthineers Recent Developments and Future Plans
Table 51. Vazyme Company Information, Head Office, and Major Competitors
Table 52. Vazyme Major Business
Table 53. Vazyme Alzheimer's Blood Tests Product and Solutions
Table 54. Vazyme Alzheimer's Blood Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Vazyme Recent Developments and Future Plans
Table 56. Hoyotek Company Information, Head Office, and Major Competitors
Table 57. Hoyotek Major Business
Table 58. Hoyotek Alzheimer's Blood Tests Product and Solutions
Table 59. Hoyotek Alzheimer's Blood Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. Hoyotek Recent Developments and Future Plans
Table 61. BGI Genomics Company Information, Head Office, and Major Competitors
Table 62. BGI Genomics Major Business
Table 63. BGI Genomics Alzheimer's Blood Tests Product and Solutions
Table 64. BGI Genomics Alzheimer's Blood Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. BGI Genomics Recent Developments and Future Plans
Table 66. Kemei Diagnostics Company Information, Head Office, and Major Competitors
Table 67. Kemei Diagnostics Major Business
Table 68. Kemei Diagnostics Alzheimer's Blood Tests Product and Solutions
Table 69. Kemei Diagnostics Alzheimer's Blood Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. Kemei Diagnostics Recent Developments and Future Plans
Table 71. Maya Lightyear Company Information, Head Office, and Major Competitors
Table 72. Maya Lightyear Major Business
Table 73. Maya Lightyear Alzheimer's Blood Tests Product and Solutions
Table 74. Maya Lightyear Alzheimer's Blood Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. Maya Lightyear Recent Developments and Future Plans
Table 76. Global Alzheimer's Blood Tests Revenue (USD Million) by Players (2021-2026)
Table 77. Global Alzheimer's Blood Tests Revenue Share by Players (2021-2026)
Table 78. Breakdown of Alzheimer's Blood Tests by Company Type (Tier 1, Tier 2, and Tier 3)
Table 79. Market Position of Players in Alzheimer's Blood Tests, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 80. Head Office of Key Alzheimer's Blood Tests Players
Table 81. Alzheimer's Blood Tests Market: Company Product Type Footprint
Table 82. Alzheimer's Blood Tests Market: Company Product Application Footprint
Table 83. Alzheimer's Blood Tests New Market Entrants and Barriers to Market Entry
Table 84. Alzheimer's Blood Tests Mergers, Acquisition, Agreements, and Collaborations
Table 85. Global Alzheimer's Blood Tests Consumption Value (USD Million) by Type (2021-2026)
Table 86. Global Alzheimer's Blood Tests Consumption Value Share by Type (2021-2026)
Table 87. Global Alzheimer's Blood Tests Consumption Value Forecast by Type (2027-2032)
Table 88. Global Alzheimer's Blood Tests Consumption Value by Application (2021-2026)
Table 89. Global Alzheimer's Blood Tests Consumption Value Forecast by Application (2027-2032)
Table 90. North America Alzheimer's Blood Tests Consumption Value by Type (2021-2026) & (USD Million)
Table 91. North America Alzheimer's Blood Tests Consumption Value by Type (2027-2032) & (USD Million)
Table 92. North America Alzheimer's Blood Tests Consumption Value by Application (2021-2026) & (USD Million)
Table 93. North America Alzheimer's Blood Tests Consumption Value by Application (2027-2032) & (USD Million)
Table 94. North America Alzheimer's Blood Tests Consumption Value by Country (2021-2026) & (USD Million)
Table 95. North America Alzheimer's Blood Tests Consumption Value by Country (2027-2032) & (USD Million)
Table 96. Europe Alzheimer's Blood Tests Consumption Value by Type (2021-2026) & (USD Million)
Table 97. Europe Alzheimer's Blood Tests Consumption Value by Type (2027-2032) & (USD Million)
Table 98. Europe Alzheimer's Blood Tests Consumption Value by Application (2021-2026) & (USD Million)
Table 99. Europe Alzheimer's Blood Tests Consumption Value by Application (2027-2032) & (USD Million)
Table 100. Europe Alzheimer's Blood Tests Consumption Value by Country (2021-2026) & (USD Million)
Table 101. Europe Alzheimer's Blood Tests Consumption Value by Country (2027-2032) & (USD Million)
Table 102. Asia-Pacific Alzheimer's Blood Tests Consumption Value by Type (2021-2026) & (USD Million)
Table 103. Asia-Pacific Alzheimer's Blood Tests Consumption Value by Type (2027-2032) & (USD Million)
Table 104. Asia-Pacific Alzheimer's Blood Tests Consumption Value by Application (2021-2026) & (USD Million)
Table 105. Asia-Pacific Alzheimer's Blood Tests Consumption Value by Application (2027-2032) & (USD Million)
Table 106. Asia-Pacific Alzheimer's Blood Tests Consumption Value by Region (2021-2026) & (USD Million)
Table 107. Asia-Pacific Alzheimer's Blood Tests Consumption Value by Region (2027-2032) & (USD Million)
Table 108. South America Alzheimer's Blood Tests Consumption Value by Type (2021-2026) & (USD Million)
Table 109. South America Alzheimer's Blood Tests Consumption Value by Type (2027-2032) & (USD Million)
Table 110. South America Alzheimer's Blood Tests Consumption Value by Application (2021-2026) & (USD Million)
Table 111. South America Alzheimer's Blood Tests Consumption Value by Application (2027-2032) & (USD Million)
Table 112. South America Alzheimer's Blood Tests Consumption Value by Country (2021-2026) & (USD Million)
Table 113. South America Alzheimer's Blood Tests Consumption Value by Country (2027-2032) & (USD Million)
Table 114. Middle East & Africa Alzheimer's Blood Tests Consumption Value by Type (2021-2026) & (USD Million)
Table 115. Middle East & Africa Alzheimer's Blood Tests Consumption Value by Type (2027-2032) & (USD Million)
Table 116. Middle East & Africa Alzheimer's Blood Tests Consumption Value by Application (2021-2026) & (USD Million)
Table 117. Middle East & Africa Alzheimer's Blood Tests Consumption Value by Application (2027-2032) & (USD Million)
Table 118. Middle East & Africa Alzheimer's Blood Tests Consumption Value by Country (2021-2026) & (USD Million)
Table 119. Middle East & Africa Alzheimer's Blood Tests Consumption Value by Country (2027-2032) & (USD Million)
Table 120. Global Key Players of Alzheimer's Blood Tests Upstream (Raw Materials)
Table 121. Global Alzheimer's Blood Tests Typical Customers
Table 1. Global Alzheimer's Blood Tests Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Alzheimer's Blood Tests Consumption Value Testing Technology, (USD Million), 2021 & 2025 & 2032
Table 3. Global Alzheimer's Blood Tests Consumption Value Commercialization Status, (USD Million), 2021 & 2025 & 2032
Table 4. Global Alzheimer's Blood Tests Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Alzheimer's Blood Tests Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Alzheimer's Blood Tests Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Roche Company Information, Head Office, and Major Competitors
Table 8. Roche Major Business
Table 9. Roche Alzheimer's Blood Tests Product and Solutions
Table 10. Roche Alzheimer's Blood Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Roche Recent Developments and Future Plans
Table 12. Fujirebio Company Information, Head Office, and Major Competitors
Table 13. Fujirebio Major Business
Table 14. Fujirebio Alzheimer's Blood Tests Product and Solutions
Table 15. Fujirebio Alzheimer's Blood Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Fujirebio Recent Developments and Future Plans
Table 17. Sysmex Company Information, Head Office, and Major Competitors
Table 18. Sysmex Major Business
Table 19. Sysmex Alzheimer's Blood Tests Product and Solutions
Table 20. Sysmex Alzheimer's Blood Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. Shimadzu Company Information, Head Office, and Major Competitors
Table 22. Shimadzu Major Business
Table 23. Shimadzu Alzheimer's Blood Tests Product and Solutions
Table 24. Shimadzu Alzheimer's Blood Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. Shimadzu Recent Developments and Future Plans
Table 26. Diadem Company Information, Head Office, and Major Competitors
Table 27. Diadem Major Business
Table 28. Diadem Alzheimer's Blood Tests Product and Solutions
Table 29. Diadem Alzheimer's Blood Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Diadem Recent Developments and Future Plans
Table 31. Quanterix Company Information, Head Office, and Major Competitors
Table 32. Quanterix Major Business
Table 33. Quanterix Alzheimer's Blood Tests Product and Solutions
Table 34. Quanterix Alzheimer's Blood Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Quanterix Recent Developments and Future Plans
Table 36. ALZpath Company Information, Head Office, and Major Competitors
Table 37. ALZpath Major Business
Table 38. ALZpath Alzheimer's Blood Tests Product and Solutions
Table 39. ALZpath Alzheimer's Blood Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. ALZpath Recent Developments and Future Plans
Table 41. Beckman Coulter Diagnostics Company Information, Head Office, and Major Competitors
Table 42. Beckman Coulter Diagnostics Major Business
Table 43. Beckman Coulter Diagnostics Alzheimer's Blood Tests Product and Solutions
Table 44. Beckman Coulter Diagnostics Alzheimer's Blood Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Beckman Coulter Diagnostics Recent Developments and Future Plans
Table 46. Siemens Healthineers Company Information, Head Office, and Major Competitors
Table 47. Siemens Healthineers Major Business
Table 48. Siemens Healthineers Alzheimer's Blood Tests Product and Solutions
Table 49. Siemens Healthineers Alzheimer's Blood Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Siemens Healthineers Recent Developments and Future Plans
Table 51. Vazyme Company Information, Head Office, and Major Competitors
Table 52. Vazyme Major Business
Table 53. Vazyme Alzheimer's Blood Tests Product and Solutions
Table 54. Vazyme Alzheimer's Blood Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Vazyme Recent Developments and Future Plans
Table 56. Hoyotek Company Information, Head Office, and Major Competitors
Table 57. Hoyotek Major Business
Table 58. Hoyotek Alzheimer's Blood Tests Product and Solutions
Table 59. Hoyotek Alzheimer's Blood Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. Hoyotek Recent Developments and Future Plans
Table 61. BGI Genomics Company Information, Head Office, and Major Competitors
Table 62. BGI Genomics Major Business
Table 63. BGI Genomics Alzheimer's Blood Tests Product and Solutions
Table 64. BGI Genomics Alzheimer's Blood Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. BGI Genomics Recent Developments and Future Plans
Table 66. Kemei Diagnostics Company Information, Head Office, and Major Competitors
Table 67. Kemei Diagnostics Major Business
Table 68. Kemei Diagnostics Alzheimer's Blood Tests Product and Solutions
Table 69. Kemei Diagnostics Alzheimer's Blood Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. Kemei Diagnostics Recent Developments and Future Plans
Table 71. Maya Lightyear Company Information, Head Office, and Major Competitors
Table 72. Maya Lightyear Major Business
Table 73. Maya Lightyear Alzheimer's Blood Tests Product and Solutions
Table 74. Maya Lightyear Alzheimer's Blood Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. Maya Lightyear Recent Developments and Future Plans
Table 76. Global Alzheimer's Blood Tests Revenue (USD Million) by Players (2021-2026)
Table 77. Global Alzheimer's Blood Tests Revenue Share by Players (2021-2026)
Table 78. Breakdown of Alzheimer's Blood Tests by Company Type (Tier 1, Tier 2, and Tier 3)
Table 79. Market Position of Players in Alzheimer's Blood Tests, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 80. Head Office of Key Alzheimer's Blood Tests Players
Table 81. Alzheimer's Blood Tests Market: Company Product Type Footprint
Table 82. Alzheimer's Blood Tests Market: Company Product Application Footprint
Table 83. Alzheimer's Blood Tests New Market Entrants and Barriers to Market Entry
Table 84. Alzheimer's Blood Tests Mergers, Acquisition, Agreements, and Collaborations
Table 85. Global Alzheimer's Blood Tests Consumption Value (USD Million) by Type (2021-2026)
Table 86. Global Alzheimer's Blood Tests Consumption Value Share by Type (2021-2026)
Table 87. Global Alzheimer's Blood Tests Consumption Value Forecast by Type (2027-2032)
Table 88. Global Alzheimer's Blood Tests Consumption Value by Application (2021-2026)
Table 89. Global Alzheimer's Blood Tests Consumption Value Forecast by Application (2027-2032)
Table 90. North America Alzheimer's Blood Tests Consumption Value by Type (2021-2026) & (USD Million)
Table 91. North America Alzheimer's Blood Tests Consumption Value by Type (2027-2032) & (USD Million)
Table 92. North America Alzheimer's Blood Tests Consumption Value by Application (2021-2026) & (USD Million)
Table 93. North America Alzheimer's Blood Tests Consumption Value by Application (2027-2032) & (USD Million)
Table 94. North America Alzheimer's Blood Tests Consumption Value by Country (2021-2026) & (USD Million)
Table 95. North America Alzheimer's Blood Tests Consumption Value by Country (2027-2032) & (USD Million)
Table 96. Europe Alzheimer's Blood Tests Consumption Value by Type (2021-2026) & (USD Million)
Table 97. Europe Alzheimer's Blood Tests Consumption Value by Type (2027-2032) & (USD Million)
Table 98. Europe Alzheimer's Blood Tests Consumption Value by Application (2021-2026) & (USD Million)
Table 99. Europe Alzheimer's Blood Tests Consumption Value by Application (2027-2032) & (USD Million)
Table 100. Europe Alzheimer's Blood Tests Consumption Value by Country (2021-2026) & (USD Million)
Table 101. Europe Alzheimer's Blood Tests Consumption Value by Country (2027-2032) & (USD Million)
Table 102. Asia-Pacific Alzheimer's Blood Tests Consumption Value by Type (2021-2026) & (USD Million)
Table 103. Asia-Pacific Alzheimer's Blood Tests Consumption Value by Type (2027-2032) & (USD Million)
Table 104. Asia-Pacific Alzheimer's Blood Tests Consumption Value by Application (2021-2026) & (USD Million)
Table 105. Asia-Pacific Alzheimer's Blood Tests Consumption Value by Application (2027-2032) & (USD Million)
Table 106. Asia-Pacific Alzheimer's Blood Tests Consumption Value by Region (2021-2026) & (USD Million)
Table 107. Asia-Pacific Alzheimer's Blood Tests Consumption Value by Region (2027-2032) & (USD Million)
Table 108. South America Alzheimer's Blood Tests Consumption Value by Type (2021-2026) & (USD Million)
Table 109. South America Alzheimer's Blood Tests Consumption Value by Type (2027-2032) & (USD Million)
Table 110. South America Alzheimer's Blood Tests Consumption Value by Application (2021-2026) & (USD Million)
Table 111. South America Alzheimer's Blood Tests Consumption Value by Application (2027-2032) & (USD Million)
Table 112. South America Alzheimer's Blood Tests Consumption Value by Country (2021-2026) & (USD Million)
Table 113. South America Alzheimer's Blood Tests Consumption Value by Country (2027-2032) & (USD Million)
Table 114. Middle East & Africa Alzheimer's Blood Tests Consumption Value by Type (2021-2026) & (USD Million)
Table 115. Middle East & Africa Alzheimer's Blood Tests Consumption Value by Type (2027-2032) & (USD Million)
Table 116. Middle East & Africa Alzheimer's Blood Tests Consumption Value by Application (2021-2026) & (USD Million)
Table 117. Middle East & Africa Alzheimer's Blood Tests Consumption Value by Application (2027-2032) & (USD Million)
Table 118. Middle East & Africa Alzheimer's Blood Tests Consumption Value by Country (2021-2026) & (USD Million)
Table 119. Middle East & Africa Alzheimer's Blood Tests Consumption Value by Country (2027-2032) & (USD Million)
Table 120. Global Key Players of Alzheimer's Blood Tests Upstream (Raw Materials)
Table 121. Global Alzheimer's Blood Tests Typical Customers
LIST OF FIGURES
Figure 1. Alzheimer's Blood Tests Picture
Figure 2. Global Alzheimer's Blood Tests Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Alzheimer's Blood Tests Consumption Value Market Share by Type in 2025
Figure 4. Single Biomarker Tests
Figure 5. Multi-Biomarker Panel Tests
Figure 6. Others
Figure 7. Global Alzheimer's Blood Tests Consumption Value Testing Technology, (USD Million), 2021 & 2025 & 2032
Figure 8. Global Alzheimer's Blood Tests Consumption Value Market Share Testing Technology in 2025
Figure 9. Chemiluminescent Immunoassay
Figure 10. Single-Molecule and Ultra-Sensitive Immunoassay
Figure 11. Mass Spectrometry-Based Testing
Figure 12. Others
Figure 13. Global Alzheimer's Blood Tests Consumption Value Commercialization Status, (USD Million), 2021 & 2025 & 2032
Figure 14. Global Alzheimer's Blood Tests Consumption Value Market Share Commercialization Status in 2025
Figure 15. Commercialized Products
Figure 16. Products under Development or Registration
Figure 17. Research Use Only Products
Figure 18. Global Alzheimer's Blood Tests Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 19. Alzheimer's Blood Tests Consumption Value Market Share by Application in 2025
Figure 20. Clinical Use Picture
Figure 21. Non-Clinical Use Picture
Figure 22. Global Alzheimer's Blood Tests Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 23. Global Alzheimer's Blood Tests Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 24. Global Market Alzheimer's Blood Tests Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 25. Global Alzheimer's Blood Tests Consumption Value Market Share by Region (2021-2032)
Figure 26. Global Alzheimer's Blood Tests Consumption Value Market Share by Region in 2025
Figure 27. North America Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 28. Europe Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 29. Asia-Pacific Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 30. South America Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 31. Middle East & Africa Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 32. Company Three Recent Developments and Future Plans
Figure 33. Global Alzheimer's Blood Tests Revenue Share by Players in 2025
Figure 34. Alzheimer's Blood Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 35. Market Share of Alzheimer's Blood Tests by Player Revenue in 2025
Figure 36. Top 3 Alzheimer's Blood Tests Players Market Share in 2025
Figure 37. Top 6 Alzheimer's Blood Tests Players Market Share in 2025
Figure 38. Global Alzheimer's Blood Tests Consumption Value Share by Type (2021-2026)
Figure 39. Global Alzheimer's Blood Tests Market Share Forecast by Type (2027-2032)
Figure 40. Global Alzheimer's Blood Tests Consumption Value Share by Application (2021-2026)
Figure 41. Global Alzheimer's Blood Tests Market Share Forecast by Application (2027-2032)
Figure 42. North America Alzheimer's Blood Tests Consumption Value Market Share by Type (2021-2032)
Figure 43. North America Alzheimer's Blood Tests Consumption Value Market Share by Application (2021-2032)
Figure 44. North America Alzheimer's Blood Tests Consumption Value Market Share by Country (2021-2032)
Figure 45. United States Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 46. Canada Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 47. Mexico Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 48. Europe Alzheimer's Blood Tests Consumption Value Market Share by Type (2021-2032)
Figure 49. Europe Alzheimer's Blood Tests Consumption Value Market Share by Application (2021-2032)
Figure 50. Europe Alzheimer's Blood Tests Consumption Value Market Share by Country (2021-2032)
Figure 51. Germany Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 52. France Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 53. United Kingdom Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 54. Russia Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 55. Italy Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 56. Asia-Pacific Alzheimer's Blood Tests Consumption Value Market Share by Type (2021-2032)
Figure 57. Asia-Pacific Alzheimer's Blood Tests Consumption Value Market Share by Application (2021-2032)
Figure 58. Asia-Pacific Alzheimer's Blood Tests Consumption Value Market Share by Region (2021-2032)
Figure 59. China Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 60. Japan Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 61. South Korea Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 62. India Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 63. Southeast Asia Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 64. Australia Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 65. South America Alzheimer's Blood Tests Consumption Value Market Share by Type (2021-2032)
Figure 66. South America Alzheimer's Blood Tests Consumption Value Market Share by Application (2021-2032)
Figure 67. South America Alzheimer's Blood Tests Consumption Value Market Share by Country (2021-2032)
Figure 68. Brazil Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 69. Argentina Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 70. Middle East & Africa Alzheimer's Blood Tests Consumption Value Market Share by Type (2021-2032)
Figure 71. Middle East & Africa Alzheimer's Blood Tests Consumption Value Market Share by Application (2021-2032)
Figure 72. Middle East & Africa Alzheimer's Blood Tests Consumption Value Market Share by Country (2021-2032)
Figure 73. Turkey Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 74. Saudi Arabia Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 75. UAE Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 76. Alzheimer's Blood Tests Market Drivers
Figure 77. Alzheimer's Blood Tests Market Restraints
Figure 78. Alzheimer's Blood Tests Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Alzheimer's Blood Tests Industrial Chain
Figure 81. Methodology
Figure 82. Research Process and Data Source
Figure 1. Alzheimer's Blood Tests Picture
Figure 2. Global Alzheimer's Blood Tests Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Alzheimer's Blood Tests Consumption Value Market Share by Type in 2025
Figure 4. Single Biomarker Tests
Figure 5. Multi-Biomarker Panel Tests
Figure 6. Others
Figure 7. Global Alzheimer's Blood Tests Consumption Value Testing Technology, (USD Million), 2021 & 2025 & 2032
Figure 8. Global Alzheimer's Blood Tests Consumption Value Market Share Testing Technology in 2025
Figure 9. Chemiluminescent Immunoassay
Figure 10. Single-Molecule and Ultra-Sensitive Immunoassay
Figure 11. Mass Spectrometry-Based Testing
Figure 12. Others
Figure 13. Global Alzheimer's Blood Tests Consumption Value Commercialization Status, (USD Million), 2021 & 2025 & 2032
Figure 14. Global Alzheimer's Blood Tests Consumption Value Market Share Commercialization Status in 2025
Figure 15. Commercialized Products
Figure 16. Products under Development or Registration
Figure 17. Research Use Only Products
Figure 18. Global Alzheimer's Blood Tests Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 19. Alzheimer's Blood Tests Consumption Value Market Share by Application in 2025
Figure 20. Clinical Use Picture
Figure 21. Non-Clinical Use Picture
Figure 22. Global Alzheimer's Blood Tests Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 23. Global Alzheimer's Blood Tests Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 24. Global Market Alzheimer's Blood Tests Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 25. Global Alzheimer's Blood Tests Consumption Value Market Share by Region (2021-2032)
Figure 26. Global Alzheimer's Blood Tests Consumption Value Market Share by Region in 2025
Figure 27. North America Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 28. Europe Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 29. Asia-Pacific Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 30. South America Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 31. Middle East & Africa Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 32. Company Three Recent Developments and Future Plans
Figure 33. Global Alzheimer's Blood Tests Revenue Share by Players in 2025
Figure 34. Alzheimer's Blood Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 35. Market Share of Alzheimer's Blood Tests by Player Revenue in 2025
Figure 36. Top 3 Alzheimer's Blood Tests Players Market Share in 2025
Figure 37. Top 6 Alzheimer's Blood Tests Players Market Share in 2025
Figure 38. Global Alzheimer's Blood Tests Consumption Value Share by Type (2021-2026)
Figure 39. Global Alzheimer's Blood Tests Market Share Forecast by Type (2027-2032)
Figure 40. Global Alzheimer's Blood Tests Consumption Value Share by Application (2021-2026)
Figure 41. Global Alzheimer's Blood Tests Market Share Forecast by Application (2027-2032)
Figure 42. North America Alzheimer's Blood Tests Consumption Value Market Share by Type (2021-2032)
Figure 43. North America Alzheimer's Blood Tests Consumption Value Market Share by Application (2021-2032)
Figure 44. North America Alzheimer's Blood Tests Consumption Value Market Share by Country (2021-2032)
Figure 45. United States Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 46. Canada Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 47. Mexico Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 48. Europe Alzheimer's Blood Tests Consumption Value Market Share by Type (2021-2032)
Figure 49. Europe Alzheimer's Blood Tests Consumption Value Market Share by Application (2021-2032)
Figure 50. Europe Alzheimer's Blood Tests Consumption Value Market Share by Country (2021-2032)
Figure 51. Germany Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 52. France Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 53. United Kingdom Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 54. Russia Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 55. Italy Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 56. Asia-Pacific Alzheimer's Blood Tests Consumption Value Market Share by Type (2021-2032)
Figure 57. Asia-Pacific Alzheimer's Blood Tests Consumption Value Market Share by Application (2021-2032)
Figure 58. Asia-Pacific Alzheimer's Blood Tests Consumption Value Market Share by Region (2021-2032)
Figure 59. China Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 60. Japan Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 61. South Korea Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 62. India Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 63. Southeast Asia Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 64. Australia Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 65. South America Alzheimer's Blood Tests Consumption Value Market Share by Type (2021-2032)
Figure 66. South America Alzheimer's Blood Tests Consumption Value Market Share by Application (2021-2032)
Figure 67. South America Alzheimer's Blood Tests Consumption Value Market Share by Country (2021-2032)
Figure 68. Brazil Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 69. Argentina Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 70. Middle East & Africa Alzheimer's Blood Tests Consumption Value Market Share by Type (2021-2032)
Figure 71. Middle East & Africa Alzheimer's Blood Tests Consumption Value Market Share by Application (2021-2032)
Figure 72. Middle East & Africa Alzheimer's Blood Tests Consumption Value Market Share by Country (2021-2032)
Figure 73. Turkey Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 74. Saudi Arabia Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 75. UAE Alzheimer's Blood Tests Consumption Value (2021-2032) & (USD Million)
Figure 76. Alzheimer's Blood Tests Market Drivers
Figure 77. Alzheimer's Blood Tests Market Restraints
Figure 78. Alzheimer's Blood Tests Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Alzheimer's Blood Tests Industrial Chain
Figure 81. Methodology
Figure 82. Research Process and Data Source
